42,108 Shares in Corteva, Inc. $CTVA Purchased by Millington Financial Advisors LLC

Millington Financial Advisors LLC acquired a new position in Corteva, Inc. (NYSE:CTVA) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 42,108 shares of the company’s stock, valued at approximately $3,057,000. Corteva accounts for approximately 1.4% of Millington Financial Advisors LLC’s investment portfolio, making the stock its 22nd biggest holding.

Other institutional investors have also bought and sold shares of the company. Drummond Knight Asset Management Pty Ltd acquired a new stake in Corteva in the fourth quarter worth about $25,713,000. Truist Financial Corp lifted its holdings in Corteva by 4.5% in the third quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock worth $21,771,000 after purchasing an additional 13,910 shares during the period. Alberta Investment Management Corp acquired a new stake in Corteva in the third quarter worth about $5,018,000. Avior Wealth Management LLC lifted its holdings in Corteva by 464.7% in the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock valued at $2,205,000 after acquiring an additional 27,075 shares during the last quarter. Finally, HighTower Advisors LLC lifted its holdings in Corteva by 8.6% in the 3rd quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock valued at $12,352,000 after acquiring an additional 14,436 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

CTVA stock opened at $79.89 on Thursday. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63. The firm has a market capitalization of $53.43 billion, a PE ratio of 46.99, a P/E/G ratio of 2.42 and a beta of 0.59. The firm has a 50-day moving average of $81.34 and a two-hundred day moving average of $74.39.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same period in the prior year, the firm earned $1.13 earnings per share. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is currently 42.35%.

Wall Street Analyst Weigh In

CTVA has been the subject of a number of research analyst reports. JPMorgan Chase & Co. downgraded shares of Corteva from an “overweight” rating to a “neutral” rating and upped their price target for the company from $75.00 to $77.00 in a report on Thursday, February 5th. Rothschild & Co Redburn upped their price target on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Jefferies Financial Group upped their price target on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Oppenheimer upped their price target on shares of Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Finally, UBS Group upped their price target on shares of Corteva from $88.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Thirteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $88.14.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.